Showing results (31-40 of 251) with videos related to
Sort By:
Pageof 26
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1982
Pharmacokinetics of ticarcillin during cisplatin chemotherapyM Higi, L Essers, G Linzenmeier, et al.Oncology (Williston Park, N.Y.)|March 28, 1998
Fluorouracil-based combinations in the treatment of metastatic breast cancerU Klaassen, H Wilke, A Harstrick, et al.Journal of Virological Methods|April 20, 2001
Digital imaging microscopy of firefly luciferase activity to directly monitor differences in cell transduction efficiencies between AdCMVLuc and Ad5LucRGD vectors having different cell binding propertiesS Kratzer, O Mundigl, F Dicker, et al.Journal of Cancer Research and Clinical Oncology|December 8, 2004
Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantationA Hüttmann, K Schirsafi, S Seeber, et al.Seminars in Oncology|February 1, 1996
Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancerU Klaassen, A Harstrick, H Wilke, et al.Der Urologe. Ausg. A|May 1, 1993
[Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor]T Otto, M Goepel, S Seeber, et al.British Journal of Haematology|January 14, 1999
Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemiaJ K Schröder, C Kirch, S Seeber, et al.Der Urologe. Ausg. A|March 1, 1976
[Actinomycin-D therapy in testicular cancer (author's transl)]K Höffken, J Tingelhoff, S Seeber, et al.Cancer Treatment Reports|May 1, 1984
Treatment of recurrent small cell lung carcinoma with vindesine and cisplatinN Niederle, J Schütte, C G Schmidt, et al.International Journal of Cell Cloning|September 1, 1992
Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemiaU B Wandl, N Niederle, M Kranzhoff, et al.Pageof 26